Atara Biotherapeutics (ATRA) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -6.39 | -1.22 | -0.28 | -1.45 | -4.45 | -5.21 | |||
| Changes by years, y/y, % | -18% | -81% | -77% | +417% | +208% | -10.7% | |||
Atara Biotherapeutics. P/FCF
Atara Biotherapeutics. P/FCF, changes, %
Atara Biotherapeutics (ATRA) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -0.95 | -1.47 | -2.78 | -4.45 | -2.57 | -5.21 | ||
| Changes by years, y/y, % | +80% | +301% | +335% | +116% | +171% | |||
| Changes by quarters, q/q, % | -54% | +55% | +89% | +60% | -42% | |||